1. Home
  2. CWT vs IMNM Comparison

CWT vs IMNM Comparison

Compare CWT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Water Service Group

CWT

California Water Service Group

HOLD

Current Price

$45.82

Market Cap

2.6B

Sector

Utilities

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$18.58

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWT
IMNM
Founded
1926
2006
Country
United States
United States
Employees
1105
N/A
Industry
Water Supply
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CWT
IMNM
Price
$45.82
$18.58
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$55.00
$32.80
AVG Volume (30 Days)
456.1K
1.1M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
2.95%
N/A
EPS Growth
N/A
51.40
EPS
0.07
N/A
Revenue
$963,695,000.00
$6,941,000.00
Revenue This Year
$10.18
N/A
Revenue Next Year
$5.81
$1,127.34
P/E Ratio
$646.29
N/A
Revenue Growth
6.41
N/A
52 Week Low
$41.29
$7.96
52 Week High
$50.44
$27.65

Technical Indicators

Market Signals
Indicator
CWT
IMNM
Relative Strength Index (RSI) 60.24 34.55
Support Level $44.05 $16.81
Resistance Level $46.61 $19.16
Average True Range (ATR) 0.97 1.23
MACD 0.32 -0.30
Stochastic Oscillator 94.35 0.43

Price Performance

Historical Comparison
CWT
IMNM

About CWT California Water Service Group

California Water Service Group is a U.S. water and utilities holding company based in California. The company provides water utility and other related services in California, Washington, New Mexico, Hawaii and Texas through its wholly-owned subsidiaries. The bulk of the company's business consists of the production, purchase, storage, treatment, testing, distribution, and sale of water for domestic, industrial, public, and irrigation uses, and the provision of water for domestic and municipal fire protection services.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: